Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline in Hyperprolactinemic Patients
NCT01957839Phase 4Completed
- Start
- Mar 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cabergoline in hyperprolactinemia (2 arms). Primary endpoint: Effect of prolactin on vascular flow and resistance at 2 weeks. Started Mar 2010; status: completed.
02
Drugs
cabergoline
03
Conditions
hyperprolactinemia
Beyond the preview
Go deeper on NCT01957839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01957839.